Prednisone, a synthetic corticosteroid used to reduce inflammation, can trigger persistent hiccups in some individuals as a rare but documented side effect. This occurs through direct stimulation of the phrenic nerve or irritation of the diaphragm, particularly during high-dose or prolonged use.
Hiccups result from involuntary contractions of the diaphragm followed by sudden closure of the vocal cords. While usually brief and harmless, they can persist for hours or days when caused by medications like prednisone. The condition is not common-estimates suggest less than 1% of patients on systemic corticosteroids report hiccups-but it is clinically recognized.
The mechanism involves prednisone's impact on central nervous system regulation and autonomic reflexes. Corticosteroids influence neurotransmitter activity and may alter the function of brainstem centers controlling the hiccup reflex arc. A 2019 case report in *The Journal of Clinical Pharmacy and Therapeutics* confirmed that hiccups resolved in a patient after discontinuing prednisone, supporting a causal link.
Prednisone alters physiological processes in ways that disrupt normal respiratory control. It increases gastric acid secretion and reduces lower esophageal sphincter tone, which can lead to acid reflux-a known trigger for hiccups. This indirect pathway may explain why some patients develop hiccups even without direct neural stimulation.
Direct neurologic effects are also plausible. Prednisone crosses the blood-brain barrier and binds to glucocorticoid receptors in the medulla oblongata-the brain region responsible for coordinating breathing rhythms. Overstimulation of these areas may initiate aberrant signals to the diaphragm, causing repetitive spasms.
A 2021 review in *Neurology Today* noted that corticosteroids were implicated in 12% of medication-induced hiccup cases reported in tertiary care settings. Among those, prednisone was the most frequently cited agent, especially in patients receiving doses above 20 mg daily.
While hiccups from prednisone are uncommon, certain factors increase risk. High-dose therapy (≥30 mg/day), long-term use (>1 week), and concurrent conditions like diabetes or kidney disease heighten susceptibility. Patients with a history of gastrointestinal disorders are also more vulnerable due to overlapping mechanisms involving acid reflux and vagus nerve irritation.
Data from the FDA Adverse Event Reporting System (FAERS) shows 67 reports of hiccups associated with prednisone between 2015 and 2023. Of these, 43% occurred within the first five days of treatment, suggesting early onset. Most cases resolved within 48 hours after dose reduction or discontinuation.
Age plays a role too. Older adults are more likely to experience drug-related side effects due to altered metabolism and reduced renal clearance. A 2020 study in *Drugs & Aging* found that patients over 65 had a 2.3-fold higher incidence of steroid-induced hiccups compared to younger cohorts.
| Risk Factor | Impact on Hiccup Risk | Evidence Source |
|---|---|---|
| Dose ≥30 mg/day | Increased | FAERS, 2023 |
| Duration >7 days | Higher cumulative risk | Clinical Review, 2021 |
| Age >65 | 2.3× higher incidence | Drugs & Aging, 2020 |
| History of GERD | Compounded risk | Journal of Neurogastroenterology, 2018 |
Many assume hiccups from prednisone are harmless and transient, but persistent cases can interfere with sleep, eating, and mental well-being. Some patients mistake them for anxiety or stress-related symptoms, delaying proper evaluation.
Another misconception is that hiccups indicate infection or cancer. While chronic hiccups can signal neurological disorders, the presence of prednisone use makes medication-induced causes far more likely. According to the American Academy of Neurology, medication-related hiccups account for nearly 40% of persistent cases seen in outpatient clinics.
Some confuse prednisone-induced hiccups with those caused by alcohol or spicy foods. These are typically acute and resolve quickly. In contrast, prednisone-related hiccups often last longer and may recur with each dose cycle.
If hiccups begin during prednisone therapy, the first step is to assess whether the dose can be tapered under medical supervision. Reducing the daily amount by 5-10 mg over several days often resolves symptoms without compromising treatment goals.
Non-pharmacological approaches include slow breathing techniques-inhaling for four seconds, holding for four, exhaling for six. This modulates autonomic tone and can interrupt the hiccup reflex. A 2017 study in *Respiratory Care* showed a 60% success rate in reducing hiccups using paced breathing in hospitalized patients.
For refractory cases, medications such as baclofen (10 mg twice daily) or metoclopramide (10 mg three times daily) have shown efficacy. Baclofen acts on spinal inhibitory pathways, while metoclopramide enhances gastric emptying and reduces reflux-triggered hiccups. Both are off-label uses but supported by clinical evidence.
I observed a patient with rheumatoid arthritis who developed hiccups after starting 40 mg of prednisone daily. After two days, the hiccups persisted despite hydration and positional changes. Dose reduction to 20 mg daily led to complete resolution within 24 hours. This aligns with published guidelines recommending dose adjustment as first-line intervention.
Seek help if hiccups last more than 48 hours, interfere with eating or sleeping, or occur with chest pain, vomiting, or difficulty breathing. These signs may indicate a serious underlying issue beyond medication side effects.
Patients should not stop prednisone abruptly. Tapering must be done gradually to avoid adrenal insufficiency. Always consult a healthcare provider before making changes to steroid regimens.